Holdings (Monthly)
Guide ↗
Vanguard Health Care Fund
· Vanguard Specialized Funds| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | 532457108 | Apr 2024 | 3,696,560 | $3.83B | 9.76% | EC |
| 2 | AstraZeneca PLC | N/A | Apr 2024 | 11,579,638 | $2.16B | 5.49% | EC |
| 3 | Merck & Co Inc | 58933Y105 | Apr 2024 | 18,111,825 | $2.00B | 5.09% | EC |
| 4 | UnitedHealth Group Inc | 91324P102 | Apr 2024 | 4,772,250 | $1.37B | 3.49% | EC |
| 5 | Johnson & Johnson | 478160104 | Jan 2026 | 5,367,039 | $1.22B | 3.11% | EC |
| 6 | Edwards Lifesciences Corp | 28176E108 | Apr 2024 | 14,972,830 | $1.22B | 3.10% | EC |
| 7 | GSK PLC | N/A | Apr 2024 | 45,301,487 | $1.17B | 2.98% | EC |
| 8 | Danaher Corp | 235851102 | Apr 2024 | 4,836,473 | $1.06B | 2.70% | EC |
| 9 | Abbott Laboratories | 002824100 | Apr 2024 | 9,253,894 | $1.01B | 2.58% | EC |
| 10 | Intuitive Surgical Inc | 46120E602 | Apr 2024 | 1,944,873 | $980.6M | 2.50% | EC |
| 11 | Argenx SE | N/A | Apr 2024 | 1,165,992 | $980.6M | 2.50% | EC |
| 12 | Cencora Inc | 03073E105 | Apr 2024 | 2,632,712 | $945.7M | 2.41% | EC |
| 13 | UCB SA | B93562120 | Apr 2024 | 3,023,965 | $921.5M | 2.35% | EC |
| 14 | AbbVie Inc | 00287Y109 | Jan 2026 | 4,034,908 | $899.8M | 2.29% | EC |
| 15 | Medtronic PLC | G5960L103 | Jan 2026 | 8,579,526 | $883.3M | 2.25% | EC |
| 16 | Vertex Pharmaceuticals Inc | 92532F100 | Apr 2024 | 1,589,663 | $747.0M | 1.90% | EC |
| 17 | CVS Health Corp | 126650100 | Jan 2026 | 9,756,578 | $727.1M | 1.85% | EC |
| 18 | Elevance Health Inc | 036752103 | Apr 2024 | 1,879,405 | $649.8M | 1.65% | EC |
| 19 | Cardinal Health Inc | 14149Y108 | Jan 2026 | 2,840,801 | $610.4M | 1.55% | EC |
| 20 | Novartis AG | H5820Q150 | Apr 2024 | 3,795,144 | $563.1M | 1.43% | EC |
| 21 | Roche Holding AG | H69293217 | Jan 2026 | 1,206,949 | $548.8M | 1.40% | EC |
| 22 | Biogen Inc | 09062X103 | Apr 2024 | 2,913,639 | $524.1M | 1.33% | EC |
| 23 | Galderma Group AG | N/A | Apr 2024 | 2,623,305 | $489.0M | 1.25% | EC |
| 24 | Otsuka Holdings Co Ltd | N/A | Apr 2024 | 7,893,800 | $472.6M | 1.20% | EC |
| 25 | Agilent Technologies Inc | 00846U101 | Apr 2024 | 3,480,187 | $465.8M | 1.19% | EC |
| 26 | HCA Healthcare Inc | 40412C101 | Apr 2024 | 933,410 | $455.8M | 1.16% | EC |
| 27 | Chugai Pharmaceutical Co Ltd | N/A | Apr 2024 | 7,912,642 | $452.0M | 1.15% | EC |
| 28 | Alnylam Pharmaceuticals Inc | 02043Q107 | Apr 2024 | 1,309,033 | $442.5M | 1.13% | EC |
| 29 | Genmab A/S | N/A | Apr 2024 | 1,345,944 | $438.5M | 1.12% | EC |
| 30 | United Therapeutics Corp | 91307C102 | Apr 2024 | 892,079 | $418.8M | 1.07% | EC |
| 31 | Thermo Fisher Scientific Inc | 883556102 | Apr 2024 | 702,318 | $406.4M | 1.03% | EC |
| 32 | Boston Scientific Corp | 101137107 | Apr 2024 | 4,128,084 | $386.1M | 0.98% | EC |
| 33 | Shionogi & Co Ltd | N/A | Apr 2024 | 18,640,349 | $383.8M | 0.98% | EC |
| 34 | Dexcom Inc | 252131107 | Jan 2026 | 4,655,231 | $340.0M | 0.87% | EC |
| 35 | Daiichi Sankyo Co Ltd | N/A | Apr 2024 | 18,367,566 | $336.5M | 0.86% | EC |
| 36 | Ionis Pharmaceuticals Inc | 462222100 | Apr 2024 | 3,803,181 | $314.4M | 0.80% | EC |
| 37 | Bristol-Myers Squibb Co | 110122108 | Apr 2025 | 5,317,192 | $292.7M | 0.75% | EC |
| 38 | Stryker Corp | 863667101 | Jan 2026 | 748,338 | $276.6M | 0.70% | EC |
| 39 | QIAGEN NV | N/A | Apr 2024 | 5,130,344 | $275.3M | 0.70% | EC |
| 40 | STERIS PLC | G8473T100 | Jan 2026 | 1,012,472 | $265.9M | 0.68% | EC |
| 41 | Cytokinetics Inc | 23282W605 | Apr 2024 | 4,050,667 | $256.0M | 0.65% | EC |
| 42 | Ascendis Pharma A/S | N/A | Apr 2024 | 1,103,469 | $249.5M | 0.64% | EC |
| 43 | Structure Therapeutics Inc | N/A | Apr 2024 | 2,811,254 | $248.7M | 0.63% | EC |
| 44 | Eisai Co Ltd | N/A | Apr 2024 | 8,514,317 | $237.4M | 0.60% | EC |
| 45 | Regeneron Pharmaceuticals Inc | 75886F107 | Jan 2026 | 318,062 | $235.8M | 0.60% | EC |
| 46 | REVOLUTION Medicines Inc | 76155X100 | Apr 2024 | 2,383,815 | $231.1M | 0.59% | EC |
| 47 | Avantor Inc | 05352A100 | Jan 2026 | 20,480,758 | $223.6M | 0.57% | EC |
| 48 | ICON PLC | G4705A100 | Jan 2026 | 1,213,897 | $218.8M | 0.56% | EC |
| 49 | Novo Nordisk A/S | N/A | Apr 2024 | 3,482,834 | $206.8M | 0.53% | EC |
| 50 | Madrigal Pharmaceuticals Inc | 558868105 | Jan 2026 | 398,129 | $194.8M | 0.50% | EC |
| 51 | CG oncology Inc | 156944100 | Jan 2026 | 3,484,986 | $181.4M | 0.46% | EC |
| 52 | Kymera Therapeutics Inc | 501575104 | Apr 2024 | 2,449,438 | $178.0M | 0.45% | EC |
| 53 | Vaxcyte Inc | 92243G108 | Apr 2024 | 3,283,168 | $175.9M | 0.45% | EC |
| 54 | Crinetics Pharmaceuticals Inc | 22663K107 | Apr 2025 | 3,494,255 | $174.5M | 0.44% | EC |
| 55 | Bio-Techne Corp | 09073M104 | Jan 2026 | 2,720,122 | $174.3M | 0.44% | EC |
| 56 | Apellis Pharmaceuticals Inc | 03753U106 | Apr 2024 | 7,632,548 | $172.3M | 0.44% | EC |
| 57 | Option Care Health Inc | 68404L201 | Apr 2024 | 4,987,675 | $169.6M | 0.43% | EC |
| 58 | Incyte Corp | 45337C102 | Jan 2026 | 1,590,914 | $159.2M | 0.41% | EC |
| 59 | Alignment Healthcare Inc | 01625V104 | Jan 2026 | 6,972,595 | $157.1M | 0.40% | EC |
| 60 | PTC Therapeutics Inc | 69366J200 | Apr 2024 | 2,038,232 | $153.9M | 0.39% | EC |
| 61 | Encompass Health Corp | 29261A100 | Apr 2024 | 1,600,016 | $151.2M | 0.39% | EC |
| 62 | Natera Inc | 632307104 | Jan 2026 | 636,032 | $147.0M | 0.37% | EC |
| 63 | Xenon Pharmaceuticals Inc | 98420N105 | Apr 2024 | 3,546,755 | $145.5M | 0.37% | EC |
| 64 | Apogee Therapeutics Inc | 03770N101 | Apr 2024 | 2,070,953 | $135.7M | 0.35% | EC |
| 65 | Astellas Pharma Inc | N/A | Apr 2024 | 9,027,178 | $125.6M | 0.32% | EC |
| 66 | Newamsterdam Pharma Co NV | N/A | Apr 2024 | 3,953,142 | $123.0M | 0.31% | EC |
| 67 | Scholar Rock Holding Corp | 80706P103 | Jan 2026 | 2,750,253 | $121.9M | 0.31% | EC |
| 68 | BNP Paribas Securities Corp. | N/A | Apr 2024 | 120,300,000 | $120.3M | 0.31% | RA |
| 69 | Immunocore Holdings PLC | N/A | Apr 2024 | 3,657,808 | $119.1M | 0.30% | EC |
| 70 | Acadia Healthcare Co Inc | 00404A109 | Apr 2024 | 8,815,704 | $118.5M | 0.30% | EC |
| 71 | Celldex Therapeutics Inc | 15117B202 | Apr 2024 | 4,764,728 | $117.2M | 0.30% | EC |
| 72 | Duality Biotherapeutics Inc | N/A | Apr 2024 | 2,771,377 | $117.0M | 0.30% | EC |
| 73 | Bank of America Securities, LLC | N/A | Apr 2024 | 115,000,000 | $115.0M | 0.29% | RA |
| 74 | Nuvalent Inc | 670703107 | Apr 2025 | 1,054,377 | $108.5M | 0.28% | EC |
| 75 | Bank of Nova Scotia | N/A | Apr 2024 | 94,000,000 | $94.0M | 0.24% | RA |
| 76 | Soleno Therapeutics Inc | 834203309 | Jan 2026 | 2,417,215 | $93.2M | 0.24% | EC |
| 77 | Jiangsu Hengrui Pharmaceuticals Co Ltd | N/A | Apr 2024 | 9,939,973 | $87.1M | 0.22% | EC |
| 78 | Protagonist Therapeutics Inc | 74366E102 | Jan 2026 | 1,062,977 | $87.0M | 0.22% | EC |
| 79 | Arcus Biosciences Inc | 03969F109 | Jan 2026 | 4,124,859 | $86.8M | 0.22% | EC |
| 80 | Dianthus Therapeutics Inc | 252828108 | Jan 2026 | 1,574,735 | $84.1M | 0.21% | EC |
| 81 | Inspire Medical Systems Inc | 457730109 | Jan 2026 | 1,094,019 | $82.9M | 0.21% | EC |
| 82 | Nomura Securities International, Inc. | N/A | Apr 2024 | 80,000,000 | $80.0M | 0.20% | RA |
| 83 | Bank of America Securities, LLC | N/A | Apr 2024 | 72,900,000 | $72.9M | 0.19% | RA |
| 84 | Natixis SA | N/A | Apr 2024 | 71,100,000 | $71.1M | 0.18% | RA |
| 85 | JP Morgan Securities LLC | N/A | Apr 2024 | 70,000,000 | $70.0M | 0.18% | RA |
| 86 | HeartFlow Inc | 42238D107 | Jan 2026 | 2,256,545 | $67.4M | 0.17% | EC |
| 87 | Zai Lab Ltd | N/A | Apr 2024 | 36,431,700 | $60.6M | 0.15% | EC |
| 88 | Vanguard Cmt Funds-Vanguard Market Liquidity Fund | N/A | Apr 2024 | 590,392 | $59.0M | 0.15% | STIV |
| 89 | M3 Inc | J4697J108 | Jan 2026 | 4,548,053 | $56.1M | 0.14% | EC |
| 90 | Barclays Capital Inc. | N/A | Apr 2024 | 53,500,000 | $53.5M | 0.14% | RA |
| 91 | Bank of America Securities, LLC | N/A | Apr 2024 | 50,000,000 | $50.0M | 0.13% | RA |
| 92 | Shandong Weigao Group Medical Polymer Co Ltd | N/A | Apr 2024 | 77,092,000 | $49.4M | 0.13% | EC |
| 93 | Immunome Inc | 45257U108 | Jan 2026 | 1,958,141 | $48.2M | 0.12% | EC |
| 94 | Mineralys Therapeutics Inc | 603170101 | Jan 2026 | 1,215,766 | $37.6M | 0.10% | EC |
| 95 | HSBC Bank USA | N/A | Apr 2024 | 34,000,000 | $34.0M | 0.09% | RA |
| 96 | Aktis Oncology Inc | 01021M104 | Jan 2026 | 1,523,479 | $30.9M | 0.08% | EC |
| 97 | HSBC Bank USA | N/A | Apr 2024 | 15,500,000 | $15.5M | 0.04% | RA |
| 98 | Nomura Securities International, Inc. | N/A | Apr 2024 | 10,800,000 | $10.8M | 0.03% | RA |
| 99 | BNP Paribas Securities Corp. | N/A | Apr 2024 | 10,000,000 | $10.0M | 0.03% | RA |
| 100 | Credit Agricole | N/A | Apr 2024 | 8,100,000 | $8.1M | 0.02% | RA |
| 101 | GenFleet Therapeutics Shanghai Inc | N/A | Apr 2024 | 1,979,400 | $7.8M | 0.02% | EC |